UBS lowered the firm’s price target on Enovis (ENOV) to $57 from $65 and keeps a Buy rating on the shares.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENOV:
- Enovis price target lowered to $58 from $70 at Canaccord
- Enovis Corporation Reports Q2 2025 Financial Results
- Enovis: Strong Financial Performance and Positive Outlook Justify Buy Rating
- Enovis reports Q2 adjusted EPS 79c, consensus 72c
- Enovis raises FY25 adjusted EPS view to $3.05-$3.20 from $2.95-$3.10